Merit Medical Systems Inc (FRA:MM3)
€ 94.5 -1.5 (-1.56%) Market Cap: 5.66 Bil Enterprise Value: 5.94 Bil PE Ratio: 50.78 PB Ratio: 4.58 GF Score: 87/100

Merit Medical Systems Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 12:30AM GMT
Release Date Price: €71 (+4.41%)
Harry Pearson JPMorgan;Analyst

Thank you for joining us today. My name is Harry Pearson. I'm a member of JPMorgan's healthcare investment banking team. I'm pleased to be with Fred Lampropoulos and Raul Parra, Merit's CEO and Chairman and CFO. They will give a short presentation followed by Q&A.

Fred, you want to take away?

Fred Lampropoulos
Merit Medical Systems Inc - Chairman of the Board, President, Chief Executive Officer

Thank you. I'm going to step up here. Okay, good afternoon, everybody, and thank you for having us. We're delighted to be here. This is going to be the shortest presentation of the day because kickoff is in five minutes. So I'm going to whip through this pretty quickly and answer whatever questions that you might have briefly.

So okay. Well, there we are that's about 30 years ago when we were younger. And let's just talk about our business. Merit is a diverse global company with literally thousands of SKUs that cover the endoscopy business, but primarily interventional cardiology and peripheral medicine.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot